Your browser doesn't support javascript.
Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors.
Cakir, Banu.
  • Cakir B; Department of Public Health, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
J Oncol Pharm Pract ; 26(8): 2068-2069, 2020 12.
Article in English | MEDLINE | ID: covidwho-883520

Full text: Available Collection: International databases Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / COVID-19 Type of study: Observational study / Prognostic study Limits: Humans Language: English Journal: J Oncol Pharm Pract Journal subject: Pharmacy Year: 2020 Document Type: Article Affiliation country: 1078155220967100

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / COVID-19 Type of study: Observational study / Prognostic study Limits: Humans Language: English Journal: J Oncol Pharm Pract Journal subject: Pharmacy Year: 2020 Document Type: Article Affiliation country: 1078155220967100